BLD Pharm

Manufacturer

Accelerating Drug Discovery | 120,000+ US, EU, Asia Inventory | Custom Synthesis | Scale-up Production | Global Delivery

Drug Discovery ReagentsBuilding BlocksHeterocyclesBoronic AcidsCatalysts and LigandsLife ScienceInhibitors and AgonistClick Chemistry

Founded

2014

Team size

501-1000

Country

USA · Connecticut · Newington

Posts

BLD Pharm

All 1

Promotions 0

Articles 1

Videos 0

Events 0

1 posts · sorted by recency

Article

Iberdomide (CC-220), marketed as Zenbexus by Bristol-Myers Squibb (BMS), received accelerated FDA approval on August 13, 2026.

#Iberdomide#FDA#CRBN Ligands

Showing 1 of 1 published posts